Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Armata Pharmaceuticals, Inc. (APHB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/11/2023 |
8-K
| Resignation/termination of a director|
Docs:
|
"CREDIT AND SECURITY AGREEMENT Credit and Security Agreement, dated as of July 10, 2023, by and among Armata Pharmaceuticals, Inc., a Washington corporation , each Subsidiary of the Borrower listed as a “Guarantor” on the signature pages hereto , each a “ Guarantor ” and collectively, the “ Guarantors ”) and Innoviva Strategic Opportunities LLC, a Delaware limited liability company, or an affiliate thereof, as the lender . In consideration of the premises and the covenants and agreements contained herein, the parties hereto agree as follows: ARTICLE I DEFINITIONS; CERTAIN TERMS Section 1.01.     Definitions . As used in this Agreement, the following terms shall have the respective meanings indicated below:",
"FIRST AMENDMENT TO SECURED CONVERTIBLE CREDIT AND SECURITY AGREEMENT",
"Amendment No. 1 to THE Second AMENDED AND RESTATED voting agreement",
"Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics" |
|
| 11/20/2008 |
8-K
| Resignation/termination of a director |
|
|